The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2021
Filed:
Dec. 21, 2018
Applicants:
The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);
Massachusetts Institute of Technology, Cambridge, MA (US);
Inventors:
Karl Dane Wittrup, Chestnut Hill, MA (US);
Jennifer R. Cochran, Stanford, CA (US);
Byron Hua Kwan, Seattle, WA (US);
Assignee:
The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); C07K 16/24 (2006.01); A61K 38/17 (2006.01); C07K 14/55 (2006.01); A61K 38/16 (2006.01); A61K 38/38 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 45/06 (2006.01); C07K 16/40 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2013 (2013.01); A61K 38/16 (2013.01); A61K 38/179 (2013.01); A61K 38/385 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/64 (2017.08); C07K 14/55 (2013.01); C07K 16/22 (2013.01); C07K 16/249 (2013.01); C07K 16/28 (2013.01); C07K 16/2803 (2013.01); C07K 16/2812 (2013.01); C07K 16/2815 (2013.01); C07K 16/2818 (2013.01); C07K 16/30 (2013.01); C07K 16/3053 (2013.01); C07K 16/40 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/52 (2013.01); C07K 2317/71 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01); C07K 2319/70 (2013.01);
Abstract
The present invention provides a method of treating cancer with a combination of IL-2 and an integrin-binding-Fc fusion protein. The methods of the invention can be applied to a broad range of cancer types.